Daré Bioscience, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2005-01-01
- Employees
- 26
- Market Cap
- -
Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert
- First Posted Date
- 2024-11-01
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Daré Bioscience, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06668896
Contraceptive Efficacy Study of Ovaprene
- Conditions
- Contraception
- Interventions
- Device: Ovaprene
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Daré Bioscience, Inc.
- Target Recruit Count
- 656
- Registration Number
- NCT06127199
- Locations
- 🇺🇸
Precision Trials AZ, Phoenix, Arizona, United States
🇺🇸Del Sol Research Management, LLC, Tucson, Arizona, United States
🇺🇸Essential Health Access (Berkeley), Berkeley, California, United States
Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%
- Conditions
- Sexual Arousal Disorder
- Interventions
- First Posted Date
- 2023-03-13
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Daré Bioscience, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT05765487
- Locations
- 🇨🇦
Pharma Medica Research, Inc., Mississauga, Ontario, Canada
A Study of Diclofenac Gel in Women With Primary Dysmenorrhea
- Conditions
- Dysmenorrhea Primary
- Interventions
- First Posted Date
- 2023-03-02
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Daré Bioscience, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT05752526
- Locations
- 🇦🇺
PARC Clinical Research, Adelaide, Western Australia, Australia
A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women
- Conditions
- Vulvovaginal AtrophyVasomotor Symptoms
- Interventions
- Device: IVR Dose 1Device: IVR Dose 2Drug: Oral Reference
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Daré Bioscience, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT05418426
- Locations
- 🇦🇺
PARC Clinical Research, Melbourne, Australia
🇦🇺Keogh Institute for medical Research, Nedlands, Australia
Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA
- First Posted Date
- 2022-05-18
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Daré Bioscience, Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT05378269
- Locations
- 🇦🇺
Keogh Institute for Medical Research, Nedlands, Western Australia, Australia
🇦🇺PARC Clinical Research, Adelaide, Southern Australia, Australia
Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women
- Conditions
- Vasomotor SymptomsVulvovaginal Atrophy
- Interventions
- Device: IVR Dose 1Device: IVR Dose 2
- First Posted Date
- 2022-05-10
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Daré Bioscience, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT05367973
- Locations
- 🇦🇺
PARC Clinical Research, Adelaide, Southern Australia, Australia
🇦🇺Keogh Institute for Medical Research, Nedlands, Western Australia, Australia
Pharmacokinetic Study of DARE-BV1
- First Posted Date
- 2022-04-29
- Last Posted Date
- 2022-04-29
- Lead Sponsor
- Daré Bioscience, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT05354050
- Locations
- 🇺🇸
ICON Early Phase Services, LLC, San Antonio, Texas, United States
DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE)
- Conditions
- Bacterial Vaginosis
- Interventions
- Drug: DARE-BV1clindamycin phosphate vaginal gel, 2%
- First Posted Date
- 2020-05-01
- Last Posted Date
- 2022-12-08
- Lead Sponsor
- Daré Bioscience, Inc.
- Target Recruit Count
- 307
- Registration Number
- NCT04370548
- Locations
- 🇺🇸
The Jackson Clinic, PA, Jackson, Tennessee, United States
🇺🇸Eastern Virginia Medical School, Norfolk, Virginia, United States
🇺🇸New Age Medical Research Corporation, Miami, Florida, United States
Safety and Acceptability Study of a Non-Hormonal Ring
- Conditions
- Contraception
- Interventions
- Device: Ovaprene
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2022-06-08
- Lead Sponsor
- Daré Bioscience, Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT03598088
- Locations
- 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States
🇺🇸University of California at Davis, Sacramento, California, United States
🇺🇸Clinical Research Prime, Idaho Falls, Idaho, United States